Co-authored publications

David A. Scheinberg, MD, PhD and Zita Aretz · 7 publications

CSV Word

CD8 co-receptor modulates the specificity profile of the 1G4 TCR against NY-ESO-1.
Molecular therapy : the journal of the American Society of Gene Therapy · 2025
DADavid A. ScheinbergZEZita E H AretzHFHeather F Jones
PMID: 41058174PMCID: PMC12590357DOI
Challenges and solutions for therapeutic TCR-based agents.
Immunological reviews · 2023
DADavid A. ScheinbergZEZita E H AretzZMZaki MolviSPStephanie PierrePWPatrick Wallisch
PMID: 37455333PMCID: PMC11141734DOI31 citations
Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatment.
Blood advances · 2022
DADavid A. ScheinbergZEZita E H AretzCMChristopher M BourneZMZaki MolviRSRon S Gejman+1 more →
PMID: 35561310PMCID: PMC9327544DOI16 citations
A TCR mimic CAR T cell specific for NDC80 is broadly reactive with solid tumors and hematologic malignancies.
Blood · 2022
DADavid A. ScheinbergZEZita E H AretzCBChristopher BourneMLMichael LauMGMichael G Kharas
PMID: 35427421PMCID: PMC9412008DOI18 citations
Low-dose CDK4/6 inhibitors induce presentation of pathway specific MHC ligands as potential targets for cancer immunotherapy.
Oncoimmunology · 2021
DADavid A. ScheinbergZEZita E H AretzCMChristopher M Bourne
PMID: 34104540PMCID: PMC8158036DOI22 citations
Solving an MHC allele-specific bias in the reported immunopeptidome.
JCI insight · 2020
DADavid A. ScheinbergZEZita E H AretzKNKyeara N MackYBYang Bai
PMID: 32897882PMCID: PMC7566711DOI27 citations
An input-controlled model system for identification of MHC bound peptides enabling laboratory comparisons of immunopeptidome experiments.
Journal of proteomics · 2020
DADavid A. ScheinbergZEZita E H AretzRSRon S GejmanHFHeather F Jones
PMID: 32758705PMCID: PMC7484941DOI3 citations